// App-Quantinova.ai

3513 : Promoting TRAIL apoptosis signaling using 17-beta-hydroxywithanolides

Researchers

Presenter

  • Alan D. Brooks

Principal Investigators

  • Ya-ming Xu

  • E. M. Kithsiri Wijeratne

  • Poonam Tewary

  • Curtis J. Henrich

  • Cheryl L. Thomas

  • A. A. Leslie Gunatilaka

  • Thomas J. Sayers

Medical Centers

  • Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Cancer and Inflammation Program, Frederick, MD

  • Natural Products Center, University of Arizona, Tucson, AZ

  • Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD

  • SAIC-Frederick, Frederick, MD

Locations

  • United States

Companies

  • Leidos Biomedical Re

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Solid malignancies

Biomarkers

  • Drought-repressed 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Frederick National Laboratory for Cancer Research

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved